Navigation Links
Ranbaxy Gains Approval to Manufacture and Market Cefuroxime Axetil for Oral Suspension
Date:2/6/2008

Ranbaxy to Offer Both Suspension and Tablets

PRINCETON, N.J., Feb. 6 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received approval from the U.S. Food and Drug Administration to manufacture and market Cefuroxime Axetil for Oral Suspension USP, 125 mg/5mL and 250 mg/5mL. The Office of Generic Drugs, U.S. Food and Drug Administration, has determined the Ranbaxy formulations to be bioequivalent and have the same therapeutic effect as that of the reference listed drug Ceftin(R) by GlaxoSmithKline. Total annual market sales for Cefuroxime Axetil Suspension were $28.7 million (IMS - MAT: December 2007).

Cefuroxime Axetil Suspension is indicated for the treatment of pediatric patients 3 months to 12 years of age with mild to moderate infections caused by susceptible strains of the designated microorganisms in the following conditions: Pharyngitis/Tonsillitis, Acute Bacterial Otitis Media and Impetigo.

"Ranbaxy is pleased to receive this approval for Cefuroxime Axetil Suspension that now allows us to offer both dosage forms for a product that is highly prescribed. We will offer Cefuroxime Axetil Suspension as a pleasant tasting liquid intended primarily for children that will ease in the acceptance and administration of this anti-infective. This product will further expand our product portfolio of affordable generic alternatives and will be launched immediately to all classes of trade," said Jim Meehan, Vice President of Sales and Distribution for RPI.

Ranbaxy Pharmaceuticals Inc. (RPI) based in Jacksonville, Florida, is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India's largest pharmaceutical company. RPI is engaged in the sale and distribution of generic and branded prescription products in the U.S. healthcare system.

Ranbaxy Laboratories Limited, headquartered in India, is an integrated, research
'/>"/>

SOURCE Ranbaxy Laboratories Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Tablets (OTC), 5mg and 10mg
2. Ranbaxy Receives Tentative Approval For Valsartan Tablets
3. Ranbaxy First to Gain Approval to Manufacture and Market Clarithromycin for Oral Suspension, USP
4. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
5. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
6. Shareholder Class Action Filed Against American Dental Partners, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
7. Medicare Cuts in Bush Budget Shortsighted, Far Off the Mark in Protecting Seniors Long Term Care Needs, Sustaining Nursing Home Quality Gains
8. Hispanic Radio Listeners Nationwide to Support Life-Saving Efforts Against Childhood Cancer
9. Movement Against Cancer, a Cancer Patient Advocacy Group in Russia, Launches an Effort to Inform Russian Authorities and the Public About Inadequate Access of Innovative and Effective Cancer Treatments for Cancer Patients in Russia
10. National Health Care Alliance Gains New Members Against Aetnas New Anesthesia Policy
11. Obesity Action Coalition Calls on the State of Mississippi House of Representatives to Withdraw House Bill 282 Discriminating Against Those Affected by Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2015)... Tunstall Americas announces major investment in new ... service to its Medical Answering Service customers. Through ... resources, Tunstall now provides a seamless transition between a ... to ensure superior patient satisfaction. , Tunstall ... $10 million in expanded facilities and the latest telecommunication ...
(Date:5/24/2015)... Prime has announced that they have launched the second article ... individual international health insurance. Titled: The Cost of Health Insurance in ... insurance in six top expat destinations, which are also popular business ... , Singapore , China , ... , Article 2 presents an in-depth look at the ...
(Date:5/24/2015)... For people who are keen on ... 2009-2019 Market Research Report would be an useful report ... on the present market scenario of this industry. The ... Chinese market of this industry. The report summarizes key ... the manufacturers in this industry. The report is a ...
(Date:5/24/2015)... EnviroLeather™ by LDI, a leader ... a classic, rugged leather grain with enhanced stain ... including ink, to be easily removed. The collection ... corporate, healthcare, hospitality and education environments. , InkGard ... of developing products that are more sustainable, less ...
(Date:5/24/2015)... Indiana Fiber Network, LLC (IFN), the leading ... America, Inc. (MTA) has selected IFN as a fiber ... Enterprise Sales Manager, fiber route diversity and network redundancy ... provides MTA with the diverse fiber transport from their ... and voice carriers located at Henry Street in Indianapolis, ...
Breaking Medicine News(10 mins):Health News:Tunstall Introduces New Medical Answering Service for the 21st Century Practice 2Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2
... Disease Control and Prevention (CDC) say that tobacco chewers ... and tobacco use data from more than// 13,000 adults ... the two types of spit tobacco, also called smokeless ... pipes, and cigars. Spit tobacco comes in two forms, ...
... device was found using new technology which helps prevent stroke. ... looking, by ultrasound, at any blockages in the carotid arteries ... in the US have pioneered the use of a portable ... on 20 people, this was used to take two different ...
... to sleep researchers people who sleep for more or less ... study of over one million adults conducted over a six ... need eight hours sleep a night might need modifying. Looking ... to life expectancy, researchers at the University of Texas, and ...
... brain responsible for imitation may be behind the unique ... searching for roots of empathy have now found brain ... also identified a network of brain regions that are ... enable a person to distinguish the self from others.The ...
... Board of Examinations has decided to conduct tests for any ... in the country, to ensure a higher standards amongst doctors, ... next month official sources said today. , ... the Indian Gazzette yesterday, specify that students who want to ...
... people are confirmed dead from pneumonic plague in northern ... from a remote village of Himachal Pradesh state after ... ,"The sequence of tests collectively confirmed that the ... as pneumonic plague," Federal Health Minister C.P. Thakur said. ...
Cached Medicine News:Health News:The brain wave 2
(Date:5/21/2015)... 21, 2015 Research ... the addition of the "Arthroscopy Devices ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The purpose of ... the world market for Arthroscopy Devices. The ... impacting the market for these products. , ...
(Date:5/21/2015)... May 21, 2015  (MUSE Booth # 1510)What:Automating ... Record (EHR) is invaluable in any hospital setting, ... now a requirement and mainstream in healthcare, the ... the EHR is gaining traction in MEDITECH facilities.During ... RN, Site Project Manager & Clinical Analyst at ...
(Date:5/21/2015)... May 21, 2015 ... - Zwecks Leistungsvergleich zur Expertise und ... EG-Mitgliedstaaten verwiesen, in denen uneingeschränkt betriebsfähige ... Sie ein Aegate-Land: beispielsweise BELGIEN   ... Bekämpfung von Arzneimittelfälschungen (FMD) handelt es ...
Breaking Medicine Technology:Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 3
... TORONTO, Oct. 21 According to Millennium Research Group ... while Canada typically mimics US trends in the North ... The struggling American economy led to a shrinking market ... growth of 5.6%. The greatest discrepancy ...
... Holdings, Inc., (NYSE: HRC ) invites you to ... Health Care Conference in New York City on Tuesday, November ... are invited to listen to the live presentation via the ... at http://www.veracast.com/webcasts/opco/healthcare2010/87108251.cfm . A recorded replay of ...
Cached Medicine Technology:Dental Implant Market in Canada Experiences 5.6% Growth in 2009 While US Market Declines by 4.2% 2Dental Implant Market in Canada Experiences 5.6% Growth in 2009 While US Market Declines by 4.2% 3
... is a fully automated, user-friendly system ... labor resources and improve patient care. ... and immunoturbidimetric testing capabilities with a ... assays. It's also a powerful, intuitive ...
... proteins produced with recombinant technology, that have been ... capable of detecting the different types of T.cruzi ... with amino acid sequences repeated in tandem. SAPA ... phase of the infection, it reacts with 93% ...
Inquire...
... Medtronic Subcutaneous Lead System Model ... with the use of the ... Improved SQ design and implant ... fast and easy procedure, and ...
Medicine Products: